Terms: = Ovarian cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Diagnosis
106 results:
1. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract] [Full Text] [Related]
2. Association of pre-diagnosis specific color groups of fruit and vegetable intake with ovarian cancer survival: results from the ovarian cancer follow-up study (OOPS).
Liu YY; Gong TT; Li YZ; Xu HL; Zheng G; Liu FH; Qin X; Xiao Q; Wu QJ; Huang DH; Gao S; Zhao YH
Food Funct; 2023 Sep; 14(18):8442-8452. PubMed ID: 37622277
[No Abstract] [Full Text] [Related]
3. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial ovarian cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract] [Full Text] [Related]
4. High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma.
Ghafour AA; Odemis DA; Tuncer SB; Kurt B; Saral MA; Erciyas SK; Erdogan OS; Celik B; Saip P; Yazici H
J Ovarian Res; 2021 Oct; 14(1):131. PubMed ID: 34629107
[TBL] [Abstract] [Full Text] [Related]
5. [Heredity and cancer].
Docampo E; Martin M; Gangolf M; Harvengt J; Bulk S; Segers K; Leroi N; Lete C; Palmariciotti V; Freire Chadrina V; Lambert F; Bours V
Rev Med Liege; 2021 May; 76(5-6):327-336. PubMed ID: 34080359
[TBL] [Abstract] [Full Text] [Related]
6. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract] [Full Text] [Related]
7. Differentiation of Endometriomas from Hemorrhagic Cysts at Magnetic Resonance: The Role of Quantitative Signal Intensity Measurements.
Lupean RA; Ștefan PA; Lebovici A; Csutak C; Rusu GM; Mihu CM
Curr Med Imaging; 2021; 17(4):524-531. PubMed ID: 33115394
[TBL] [Abstract] [Full Text] [Related]
8. Serum Albumin as a Predictor of Survival after Interval Debulking Surgery for Advanced ovarian cancer (AOC): A Retrospective Study.
Dai D; Balega J; Sundar S; Kehoe S; Elattar A; Phillips A; Singh K
J Invest Surg; 2022 Feb; 35(2):426-431. PubMed ID: 33021127
[TBL] [Abstract] [Full Text] [Related]
9. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract] [Full Text] [Related]
10. Vegetable and Fruit Consumption and Prognosis Among cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies.
Hurtado-Barroso S; Trius-Soler M; Lamuela-Raventós RM; Zamora-Ros R
Adv Nutr; 2020 Nov; 11(6):1569-1582. PubMed ID: 32717747
[TBL] [Abstract] [Full Text] [Related]
11. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D; Glehen O; Quenet F; Guilloit JM; Bereder JM; Lorimier G; Thibaudeau E; Ghouti L; Pinto A; Tuech JJ; Kianmanesh R; Carretier M; Marchal F; Arvieux C; Brigand C; Meeus P; Rat P; Durand-Fontanier S; Mariani P; Lakkis Z; Loi V; Pirro N; Sabbagh C; Texier M; Elias D;
Lancet Oncol; 2020 Sep; 21(9):1147-1154. PubMed ID: 32717180
[TBL] [Abstract] [Full Text] [Related]
12. Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin.
Rose PG; Fu F; Chambers LM; Mei L; De Bernardo R; Prendes BL; Lamarre E
Anticancer Drugs; 2020 Aug; 31(7):747-750. PubMed ID: 32697468
[TBL] [Abstract] [Full Text] [Related]
13. A healthy lifestyle and survival among women with ovarian cancer.
Hansen JM; Nagle CM; Ibiebele TI; Grant PT; Obermair A; Friedlander ML; DeFazio A; Webb PM;
Int J Cancer; 2020 Dec; 147(12):3361-3369. PubMed ID: 32542708
[TBL] [Abstract] [Full Text] [Related]
14. Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.
Davidson B; McFadden E; Holth A; Brunetti M; Flørenes VA
Virchows Arch; 2020 Dec; 477(6):857-864. PubMed ID: 32533344
[TBL] [Abstract] [Full Text] [Related]
15. Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer.
Li M; Tan J; Zhang Y; Ai C; Wang H; Zhang H; Jin Y; Chen Y
Abdom Radiol (NY); 2021 Jun; 46(6):2367-2375. PubMed ID: 32424610
[TBL] [Abstract] [Full Text] [Related]
16. The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23-a likely pathogenic variant with reduced penetrance?
Høberg-Vetti H; Ognedal E; Buisson A; Vamre TBA; Ariansen S; Hoover JM; Eide GE; Houge G; Fiskerstrand T; Haukanes BI; Bjorvatn C; Knappskog PM
Eur J Hum Genet; 2020 Aug; 28(8):1078-1086. PubMed ID: 32203205
[TBL] [Abstract] [Full Text] [Related]
17. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
[TBL] [Abstract] [Full Text] [Related]
18. The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer.
Gülseren V; Çakır İ; Özdemir İA; Sancı M; Gökçü M; Güngördük K
Curr Probl Cancer; 2020 Aug; 44(4):100536. PubMed ID: 31980146
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
Kraemer D; Azzarello-Burri S; Steindl K; Boonsawat P; Zweier M; Dedes KJ; Joset P; Fink D; Rauch A
Swiss Med Wkly; 2019 Aug; 149():w20092. PubMed ID: 31422574
[TBL] [Abstract] [Full Text] [Related]
20. Paper based immunosensing of ovarian cancer tumor protein CA 125 using novel nano-ink: A new platform for efficient diagnosis of cancer and biomedical analysis using microfluidic paper-based analytical devices (μPAD).
Bahavarnia F; Saadati A; Hassanpour S; Hasanzadeh M; Shadjou N; Hassanzadeh A
Int J Biol Macromol; 2019 Oct; 138():744-754. PubMed ID: 31326512
[TBL] [Abstract] [Full Text] [Related]
[Next]
